Most recently, Hesieh et al. examined response to proteasome inhibition in iPCS-derived neurons from a cohort of patients with varying degrees of AD pathology and cognitive impairment, observing an increase in tau expression [15]. This evidence concerns the gene MAPT and Alzheimer disease.